Restoration of facial form and function after severe disfigurement from burn injury by a composite facial allograft.

Authors:
Address: Division of Plastic Surgery Division of Otolaryngology Division of Transplant Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. bpomahac@partners.org
Journal:

Publication:

abstract

composite facial allotransplantation is emerging as a treatment option for severe facial disfigurements. The technical feasibility of facial transplantation has been demonstrated, and the initial clinical outcomes have been encouraging. We report an excellent functional and anatomical Restoration 1 year after face transplantation. A 59-year-old male with severe disfigurement from electrical burn injury was treated with a facial allograft composed of bone and soft tissues to restore midfacial form and function. An initial potent antirejection treatment was tapered to minimal dose of immunosuppression. There were no surgical complications. The patient demonstrated facial redness during the initial postoperative months. One acute rejection episode was reversed with a brief methylprednisolone bolus treatment. Pathological analysis and the donor's medical history suggested that rosacea transferred from the donor caused the erythema, successfully treated with topical metronidazol. Significant restoration of nasal breathing, speech, feeding, sensation and animation was achieved. The patient was highly satisfied with the esthetic result, and regained much of his capacity for normal social life. Composite facial allotransplantation, along with minimal and well-tolerated immunosuppression, was successfully utilized to restore facial form and function in a patient with severe disfigurement of the midface.

Related Articles
Human facial allotransplantation: a 2-year follow-up study.
Lancet. 2008
Human facial allotransplantation: a 2-year follow-up study.
Guo S, Han Y, Zhang X, Lu B, Yi C, Zhang H, Ma X, Wang D, Yang L, Fan X, et al. Lancet. 2008 Aug 23; 372(9639):631-8.
Review Near-total human face transplantation for a severely disfigured patient in the USA.
Lancet. 2009
Review Near-total human face transplantation for a severely disfigured patient in the USA.
Siemionow M, Papay F, Alam D, Bernard S, Djohan R, Gordon C, Hendrickson M, Lohman R, Eghtesad B, Coffman K, et al. Lancet. 2009 Jul 18; 374(9685):203-9. Epub 2009 Jul 14.
Review The world's experience with facial transplantation: what have we learned thus far?
Ann Plast Surg. 2009
Review The world's experience with facial transplantation: what have we learned thus far?
Gordon CR, Siemionow M, Papay F, Pryor L, Gatherwright J, Kodish E, Paradis C, Coffman K, Mathes D, Schneeberger S, et al. Ann Plast Surg. 2009 Nov; 63(5):572-8.
Outcomes 18 months after the first human partial face transplantation.
N Engl J Med. 2007
Outcomes 18 months after the first human partial face transplantation.
Dubernard JM, Lengelé B, Morelon E, Testelin S, Badet L, Moure C, Beziat JL, Dakpé S, Kanitakis J, D'Hauthuille C, et al. N Engl J Med. 2007 Dec 13; 357(24):2451-60.
First human face allograft: early report.
Lancet. 2006
First human face allograft: early report.
Devauchelle B, Badet L, Lengelé B, Morelon E, Testelin S, Michallet M, D'Hauthuille C, Dubernard JM. Lancet. 2006 Jul 15; 368(9531):203-9.
Noninvasive vascular images for face transplant surgical planning.
Eplasty. 2011
Noninvasive vascular images for face transplant surgical planning.
Soga S, Wake N, Bueno EM, Steigner ML, Mitsouras D, Schultz K, Diaz-Siso JR, Sisk GC, Prior R, Powers SL, et al. Eplasty. 2011; 11:e51. Epub 2011 Dec 14.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.